{"organizations": [], "uuid": "0514207f0867f0bcc11f4e1dcd8f95e35ee0b37f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novelion-says-us-district-court-ju/brief-novelion-says-u-s-district-court-judge-sentenced-unit-aegerion-pharmaceuticals-idUSFWN1PP1HG", "country": "US", "domain_rank": 408, "title": "BRIEF-Novelion Says U.S. District Court Judge Sentenced Unit Aegerion Pharmaceuticals", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-31T01:05:00.000+02:00", "replies_count": 0, "uuid": "0514207f0867f0bcc11f4e1dcd8f95e35ee0b37f"}, "author": "", "url": "https://www.reuters.com/article/brief-novelion-says-us-district-court-ju/brief-novelion-says-u-s-district-court-judge-sentenced-unit-aegerion-pharmaceuticals-idUSFWN1PP1HG", "ord_in_thread": 0, "title": "BRIEF-Novelion Says U.S. District Court Judge Sentenced Unit Aegerion Pharmaceuticals", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "brief-novelion says u.s. district court", "sentiment": "negative"}, {"name": "brief-novelion says u.s. district court judge sentenced unit aegerion pharmaceuticals", "sentiment": "negative"}, {"name": "ntenced unit aegerion pharmaceuticals reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "novelion therapeutics inc", "sentiment": "none"}, {"name": "doj", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 30 (Reuters) - Novelion Therapeutics Inc:\n* NOVELION THERAPEUTICS INC - ANNOUNCED THAT A U.S. DISTRICT COURT JUDGE HAS SENTENCED NOVELION SUBSIDIARY AEGERION PHARMACEUTICALS\n* NOVELION THERAPEUTICS INC - SENTENCE IMPOSED BY COURT IS PART OF AEGERION‘S GLOBAL SETTLEMENT OF INVESTIGATIONS BY U.S. DOJ, U.S. SEC\n* NOVELION THERAPEUTICS - COURT DECIDED NOT TO IMPOSE CRIMINAL FINE ON UNIT, ESTABLISHED RESTITUTION FUND OF $7.2 MILLION TO BE PAID IN PARTS OVER 3 YEARS\n* NOVELION THERAPEUTICS-AEGERION‘S GLOBAL SETTLEMENT HAS SERIES OF AGREEMENTS WHICH, IF APPROVED, TO RESULT IN ABOUT $40.1 MILLION PENALTY TO BE PAID OVER 3 YRS\n* NOVELION THERAPEUTICS - AS PART OF SETTLEMENT, AEGERION ALSO ENTERED 5-YEAR CORPORATE INTEGRITY AGREEMENT WITH DEPARTMENT OF HEALTH AND HUMAN SERVICES Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-01-31T01:05:00.000+02:00", "crawled": "2018-01-31T01:20:06.004+02:00", "highlightTitle": ""}